Back to Journals » OncoTargets and Therapy » Volume 9

High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy

Total article views   HTML views PDF downloads Totals
10,038 Dovepress* 9,106+ 1,515 10,621
PubMed Central* 932 340 1,272
Totals 10,038 1,855 11,893
*Since 30 December 2015
+Since July 2016

View citations on PubMed Central and Google Scholar